Frohlich Tom bought JBIO
February 12, 2026 · Form 4 insider transaction
Frohlich Tom bought 78,750 shares of Jade Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
78,750
Price
$0.00
Total value
N/A
InsiderFrohlich Tom
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 13, 2026
Shares owned after86,331
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). 1/4 of the total number of RSUs granted shall vest on each of the first four anniversaries of February 15, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.; Includes 1,581 shares acquired under the Issuer's employee stock purchase plan in December 2025.